Submit Deal

Chestnut Corporate Finance

Summary

Chestnut, founded in 2002, is an independent financial advisory firm focused on mergers & acquisitions, debt and equity financing.

Market Context

Deals Overview

Edit Data

Total Deals6

Valued Deals3

Total Value£ 1.19 B

Avg. Deal Size£ 396 M

06 Feb 2023|United States|Biotechnology

Target: CERVEAU TECHNOLOGIES

Bidder: LANTHEUS

5 Service Providers

2 Target | 3 Bidder

7 Dealmakers

1 Target | 6 Bidder

n/a

Value

19 Jan 2023|United States|Biotechnology

Target: CONCERT PHARMACEUTICALS

Bidder: SUN PHARMACEUTICAL INDUSTRIES LTD

10 Service Providers

5 Target | 5 Bidder

55 Dealmakers

40 Target | 15 Bidder

£ 346 M

Value

09 Jan 2023|United States|Biotechnology

Target: ALBIREO PHARMA

Bidder: IPSEN

10 Service Providers

7 Target | 3 Bidder

29 Dealmakers

23 Target | 6 Bidder

£ 786 M

Value

02 Aug 2021|United States|Management Consulting

Target: KYMANOX

Bidder: WESTVIEW CAPITAL PARTNERS

7 Service Providers

3 Target | 4 Bidder

5 Dealmakers

1 Target | 4 Bidder

£ 54 M

Value

06 Jan 2020|Netherlands|Alternative Fuels

Target: GOODNRG

Bidder: FINCO LOGISTICS BV

9 Service Providers

6 Target | 3 Bidder

13 Dealmakers

10 Target | 3 Bidder

n/a

Value

30 Jun 2018|United Kingdom|Iron and Steel

Target: TATA STEEL GROUP

Bidder: THYSSENKRUPP AG

18 Service Providers

7 Target | 11 Bidder

95 Dealmakers

54 Target | 42 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy